Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable SPN01 in healthy subjects and colorectal cancer
NCT06710561Phase 1Not yet recruiting
- Sponsor
- Beijing SonoPhotoNano Medical Technology
- Start
- Dec 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of SPN01 in colorectal cancer (CRC) (2 arms), sponsored by Beijing SonoPhotoNano Medical Technology. Primary endpoint: Safety and Tolerability. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
SPN01
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06710561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710561.